David S. Marks

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients with Coronary Artery Disease and Diabetic Nephropathy: A Single Center Experience

Critical review: vegetables and fruit in the prevention of chronic diseases

Graft microvascular disease in solid organ transplantation

Cryptogenic Stroke and High-Risk Patent Foramen Ovale

Action Plan for Stroke in Europe 2018–2030

Chronic kidney disease as cause of cardiovascular morbidity and mortality

Coronary microvascular dysfunction in the clinical setting: from mystery to reality

Impact of Transesophageal Echocardiography on Management in Patients With Suspected Cardioembolic Stroke

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Development of a risk adjustment mortality model using the American College of Cardiology–National Cardiovascular Data Registry (ACC–NCDR) experience: 1998–2000

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

Embolic strokes of undetermined source: the case for a new clinical construct

Cellular pathophysiology of ischemic acute kidney injury

Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology

Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis

The comparative pathobiology of atherosclerosis and restenosis

2007 Guidelines for the Management of Arterial Hypertension

Atrial Septal Aneurysm, Shunt Size, and Recurrent Stroke Risk in Patients With Patent Foramen Ovale

Drug‐eluting stents in patients with end‐stage renal disease: Meta‐analysis and systematic review of the literature

Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

Cardiorenal Syndrome

Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction

Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

Impact of acute renal failure following percutaneous coronary intervention on long-term mortality

SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement. Part II. Mitral Valve

Heparin-induced thrombocytopenia and cardiac surgery

Oxidative stress in chronic kidney disease

Bivalirudin

Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Prevalence of patent foramen ovale in cryptogenic transient ischaemic attack and non-disabling stroke at older ages: a population-based study, systematic review, and meta-analysis

Serial Angiographic Follow-Up of Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Revascularization

Prevalence of Chronic Kidney Disease in the United States

Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials

Antithrombotic Therapy During Percutaneous Coronary Intervention

Characterisation of species differences in the platelet ADP and thrombin response

Device Closure of Patent Foramen Ovale After Stroke

Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography

A contemporary overview of percutaneous coronary interventions

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease

What Does the Empirical Evidence Tell Us About the Injustice of Health Inequalities?

Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale

Administration of a Potent Antagonist of Protease-Activated Receptor-1 (PAR-1) Attenuates Vascular Restenosis Following Balloon Angioplasty in Rats

Altered Vascular Injury Responses in Mice Deficient in Protease-Activated Receptor-1

Guidelines for the Primary Prevention of Stroke

Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta‐Analysis, and New Insights From the CLOSE Study

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke

Mortality After Acute Myocardial Infarction in Hospitals That Disproportionately Treat Black Patients

Diagnosis and Management of Cerebral Venous Thrombosis

Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂

Guidelines for Adult Stroke Rehabilitation and Recovery

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: pubauth@heart.org(ask for reprint no. 71-0205).

Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials

Risk of Paradoxical Embolism (RoPE)–Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure

Right ventricular function in adult cardiovascular disease

Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism

An Updated Definition of Stroke for the 21st Century

Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Meta-Analysis: Angiotensin-Receptor Blockers in Chronic Heart Failure and High-Risk Acute Myocardial Infarction

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

Pharmacology and Clinical Use of Bivalirudin

ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary

Weekend versus Weekday Admission and Mortality from Myocardial Infarction

Practice advisory update summary: Patent foramen ovale and secondary stroke prevention

Race, baseline characteristics, and clinical outcomes after coronary intervention: The New Approaches in Coronary Interventions (NACI) registry

Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention

Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure

Mortality in Patients With Microvascular Disease

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke

Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke

Diagnostic value of visualization of the right ventricle using thallium-201 myocardial imaging.

Percutaneous Transvenous Mitral Annuloplasty